Despite extensive studies on CD4 + CD25 + regulatory T cells (Tregs) during the past decade, the progress on their clinical translation remains stagnant. Mounting evidence suggests that naturally occurring CD8 + CD122 + T cells are also Tregs with the capacity to inhibit T-cell responses and suppress autoimmunity as well as alloimmunity. In fact, they are memory-like Tregs that resemble a central memory T cell (T CM) phenotype. The mechanisms underlying their suppression are still not well understood, although they may include IL-10 production. We have recently demonstrated that programmed death-1 (PD-1) expression distinguishes between regulatory and memory CD8 + CD122 + T cells and that CD8 + CD122 + Tregs undergo faster homeostatic proliferation and are more potent in the suppression of allograft rejection than conventional CD4 + CD25 + Tregs. These findings may open a new line of investigation for accelerating effective Treg therapies in the clinic. In this review, we summarize the significant progress in this promising field of CD8 + CD122 + Treg research and discuss their phenotypes, suppressive roles in autoimmunity and alloimmunity, functional requirements, mechanisms of action and potential applications in the clinic. © 2014 CSI and USTC.
CITATION STYLE
Li, S., Xie, Q., Zeng, Y., Zou, C., Liu, X., Wu, S., … Dai, Z. (2014). A naturally occurring CD8 + CD122 + T-cell subset as a memory-like Treg family. Cellular and Molecular Immunology. Chinese Soc Immunology. https://doi.org/10.1038/cmi.2014.25
Mendeley helps you to discover research relevant for your work.